Nymox Pharmaceutical

Nymox Pharmaceutical is a company listed under the stock ticker NYMX (US).

View the org chart displaying its 6 main executives

Most searched biographies at Nymox Pharmaceutical

• Paul Averback, Chairman of the Board, President, Chief Executive O...
• James Robinson, Director
• David Morse, Director

Create your alert
to follow the executive moves at Nymox Pharmaceutical.

Nymox Pharmaceutical has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nymox Pharmaceutical

• Press Releases | NYMOX

Social media about Nymox Pharmaceutical

• Nymox Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Nymox Pharmaceutical on LinkedIn, Twitter & YouTube

Call Nymox Pharmaceutical at +1 800...

View the org chart

Register to receive your alert

Report an error